Non-Surgical Periodontal Treatment Trends, Opportunities & Forecast 2033

Non-Surgical Periodontal Treatment by Application (Hospitals, Dental Clinics), by Types (Scaling And Root Planning, Antibiotic Treatment, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Dec 11, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Dec 11, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Non-Surgical Periodontal Treatment Market Size | CAGR 7.3 Forecast 2033

Non-Surgical Periodontal Treatment Trends, Opportunities & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Dec 11, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Dec 11, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Non-Surgical Periodontal Treatment Market Overview

The Non‑Surgical Periodontal Treatment market encompasses minimally invasive therapies—such as scaling & root planing, antimicrobial agents, and laser‑based modalities—used to manage periodontal disease without operative intervention. This market is pivotal for oral health outcomes, offering cost‑effective, patient‑friendly alternatives to surgical care. According to recent industry estimates, the Non‑Surgical Periodontal Treatment market size reached approximately $3.3 billion in 2025, and the market forecast projects a robust CAGR of about 9 % from 2026 to 2033, underscoring a strong growth outlook and accelerating industry expansion across global dental practices.

Loading chart…

The market’s momentum is driven by an aging global population, rising prevalence of chronic periodontitis, and heightened awareness of oral‑systemic health links. Technology shifts—notably the adoption of diode and Er:YAG lasers—enhance clinical efficacy and patient comfort, while evolving reimbursement frameworks in North America and Europe improve provider uptake. Competitive intensity is intensifying as pharmaceutical firms expand antimicrobial portfolios and device manufacturers launch next‑generation laser platforms. Regionally, North America remains the largest market, reflecting high disposable income and advanced dental infrastructure, whereas Asia‑Pacific emerges as the fastest‑growing region, propelled by expanding middle‑class demographics, increasing urbanization, and growing investment in dental care services.

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	9.14 billion
Growth rate	CAGR of 7.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	3M; ASA Dental S.p.A; Amyndas Pharmaceutical; Carl Martin GmbH; AMD Lasers; Dentsply Sirona; Biolase; Karl Schumacher; Danaher; Steris-Hu-Friedy; Novartis AG; Deppeler SA; Planmeca Oy; Medtronic; Straumann AG; Pfizer
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Non-Surgical Periodontal Treatment market is navigating a pivotal phase where demographic shifts, technology adoption, and evolving reimbursement frameworks converge to shape its trajectory. This dynamics overview distills the primary forces influencing market size and the forthcoming growth forecast for senior decision‑makers.

Growth Drivers2 items

Rising prevalence of chronic periodontitis driven by an aging population and lifestyle‑related risk factors fuels demand for conservative care, while heightened patient awareness accelerates adoption of non‑surgical protocols, directly expanding the Non-Surgical Periodontal Treatment market size.

Breakthroughs such as laser‑assisted debridement, ultrasonic scalers with AI‑enhanced feedback, and adjunctive photodynamic therapy improve clinical outcomes and patient compliance, underpinning a robust growth forecast across both mature and emerging geographies.

Restraints2 items

Reimbursement policies remain fragmented, with many public insurers offering limited or no coverage for non‑surgical periodontal procedures, curbing patient uptake and restraining the overall market expansion.

Regulatory scrutiny for novel laser devices and antimicrobial adjuncts mandates extensive clinical validation, extending approval timelines and elevating development costs, which suppresses short‑term revenue generation.

Opportunities2 items

Tele‑periodontics platforms that combine remote imaging, AI‑driven risk scoring, and virtual coaching enable continuous monitoring, unlocking new service models and expanding the Non-Surgical Periodontal Treatment market size in digitally‑ready regions.

Co‑development agreements between dental device OEMs and pharma companies to bundle antimicrobial gels with scaling tools create differentiated portfolios, offering higher clinical value and driving the growth forecast through bundled pricing strategies.

Challenges2 items

The entry of low‑cost manufacturers from emerging economies intensifies price competition, eroding margins for incumbents and compelling them to accelerate cost‑optimization and value‑based pricing initiatives.

Supply chain volatility for specialty polymers and fiber‑optic components used in ultrasonic and laser systems raises lead times and unit costs, challenging pricing stability and affecting the overall market growth forecast.

Market Segmentation

Loading chart…

Application segmentation delineates the primary clinical uses of non‑surgical periodontal treatment and quantifies their share of the overall market. Scaling and root planing remains the cornerstone, accounting for roughly 45 % of revenue, driven by its broad adoption across general dentistry and periodontics for plaque removal and root surface decontamination. Antimicrobial therapy, including local delivery of antibiotics and chlorhexidine chips, contributes about 30 % as clinicians target bacterial biofilm eradication in moderate to severe cases, reflecting higher reimbursement rates for adjunctive drug delivery. Laser therapy represents an emerging 15 % share, leveraged for its minimally invasive debridement and hemostasis benefits, particularly in practices emphasizing technology‑driven care. The residual 10 % encompasses air‑polishing, photodynamic therapy, and other niche procedures. Collectively, these application categories shape the Non‑Surgical Periodontal Treatment segmentation landscape, guiding investment decisions and R&D prioritization across the market taxonomy.

Types segmentation classifies non‑surgical periodontal interventions by their operative mechanism rather than clinical indication. Mechanical approaches, chiefly hand and ultrasonic instruments, dominate due to their proven efficacy and low cost, underpinning the bulk of procedural volume. Chemical modalities, such as locally applied antibiotics, antiseptics, and enzymatic agents, add a pharmacologic dimension that enhances outcomes in patients with persistent infection, contributing a modest but growing portion of the market. Laser‑based treatments, distinct from mechanical scaling, employ specific wavelengths to ablate diseased tissue and sterilize pockets, driving incremental revenue in technology‑focused clinics. Photodynamic therapy utilizes light‑activated photosensitizers to disrupt bacterial colonies, representing a niche yet expanding segment as clinical evidence accumulates. Each type’s market contribution aligns with practitioner adoption curves, reimbursement structures, and evidence‑based guidelines, collectively informing the broader market taxonomy for non‑surgical periodontal care.

Non-Surgical Periodontal Treatment Segmentation Breakdown7 items

Application

Hospitals

Dental Clinics

Types

Scaling And Root Planning

Antibiotic Treatment

Others

Regional Insights

Loading chart…

The Non-Surgical Periodontal Treatment market growth is anchored by North America, which commands the largest share of the market, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast. Robust reimbursement frameworks, high oral‑health awareness, and mature distribution channels underpin North America’s leadership, whereas rapid urbanization, expanding middle‑class populations, and escalating private‑sector investments drive Asia Pacific’s acceleration.

North America: • Strong public‑private partnership models accelerate adoption of laser‑assisted and ultrasonic therapies. • Favorable insurance coverage and Medicare/Medicaid policies reduce out‑of‑pocket costs for patients. • Advanced clinical research ecosystems foster continuous product innovation.

Europe: • Unified regulatory harmonization across the EU streamlines market entry. • Growing emphasis on preventive dental care in national health agendas boosts demand. • High density of specialist clinics and well‑established supply chains enhance service accessibility.

Asia Pacific: • Surge in disposable income and heightened aesthetic awareness expand patient pools. • Government initiatives promoting oral‑health education increase early‑stage treatment uptake. • Significant capital inflows into dental technology startups accelerate ecosystem maturity.

Latin America: • Expanding private dental networks improve service reach in urban centers. • Emerging reimbursement schemes in Brazil and Mexico incentivize non‑surgical interventions. • Demographic shift toward younger, health‑conscious consumers drives volume growth.

Middle East & Africa: • Strategic investments in dental infrastructure by sovereign wealth funds elevate treatment capacity. • Rising expatriate populations create demand for internationally recognized periodontal protocols. • Government‑led oral‑health campaigns in GCC nations foster greater adoption of minimally invasive therapies.

Competitive Landscape

The Non‑Surgical Periodontal Treatment competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a sizable cohort of regional specialists. Global firms leverage scale to negotiate pricing and secure broad distribution networks, while local players differentiate through niche certifications and faster regulatory approvals in specific jurisdictions. Competitive levers centre on price elasticity, channel depth, incremental product innovation, and compliance with ISO and FDA standards. The market’s structure reflects a balance between cost‑driven competition and value‑added differentiation, where distribution strength and certification breadth often offset modest price differentials. Additionally, reimbursement frameworks in Europe and North America incentivize providers to adopt products with proven clinical outcomes, reinforcing the importance of evidence‑based positioning.

Key competitive strategies converge on inorganic growth, collaborative alliances, and portfolio diversification. Companies pursue M&A to acquire complementary technologies, while partnership agreements with dental schools or device distributors accelerate market penetration. New product launches focus on laser‑assisted debridement, antimicrobial gels, and bio‑active scaffolds, often coupled with localized manufacturing to reduce lead times. Differentiation hinges on proprietary light‑emission technology, integrated service models that bundle training with consumables, and channel strength in hospital‑based periodontal units versus retail dental chains. Cost‑advantage positioning is evident among firms that source raw materials at scale, yet margin pressure from reimbursement caps and rising compliance costs remain pervasive challenges.

3M – premium pricing combined with OEM tie‑ups.

ASA Dental S.p.A – regional expansion through local manufacturing.

Danaher – vertical integration of supply chain and distribution channels.

Dentsply Sirona – innovation pipeline targeting laser‑assisted therapies.

Novartis AG – strategic partnerships for regulatory certification support.

Planmeca Oy – cost‑advantage positioning in emerging markets.

Key Non-Surgical Periodontal Treatment Companies16 items

ASA Dental S.p.A

Amyndas Pharmaceutical

Carl Martin GmbH

AMD Lasers

Dentsply Sirona

Biolase

Karl Schumacher

Danaher

Steris-Hu-Friedy

Novartis AG

Deppeler SA

Planmeca Oy

Medtronic

Straumann AG

Pfizer

Market Ecosystem

The Non‑Surgical Periodontal Treatment ecosystem comprises upstream suppliers of clinical‑grade biomaterials, midstream manufacturers and technology developers that convert these inputs into therapeutic devices and protocols, and downstream distribution channels that deliver products to dental practices and periodontal clinics. Value is generated when raw materials meet regulatory specifications, are integrated into approved device platforms, and are supported by training and service networks that enable clinicians to apply evidence‑based protocols. Capture occurs through reimbursement mechanisms, practice‑level adoption, and data feedback loops that inform product refinements.

Raw material/component suppliers — provide FDA‑cleared polymers, antimicrobial agents, and biocompatible gels for periodontal therapies.

OEMs/manufacturers — fabricate scaling instruments, ultrasonic devices, and delivery systems according to clinical specifications.

Technology providers — develop digital imaging, AI‑driven diagnostics, and software platforms that guide treatment planning.

System integrators/EPCs — assemble hardware and software components into turnkey periodontal treatment solutions for clinics.

Distributors/channel partners — manage inventory, logistics, and regional sales outreach to dental practice networks.

Service providers/after‑sales — deliver training, maintenance, and clinical support to ensure sustained device performance.

End users/buyers — dental practitioners and periodontal specialists apply the treatments within reimbursable care pathways.

Control points in the Non‑Surgical Periodontal Treatment ecosystem reside with regulators that set material and device standards, and with large dental group purchasing organizations that shape purchasing decisions. Dependency risks include limited availability of certified biomaterials and the need for clinical evidence to satisfy reimbursement criteria. Switching costs are elevated by device‑specific training requirements and integration of software platforms, encouraging long‑term supplier relationships. Interoperability between imaging systems and treatment devices is increasingly mandated, reinforcing partnership models. Regional variations appear in regulatory timelines and reimbursement structures, influencing the speed of adoption across markets.

Recent Industry Insights

In the past 12–18 months the Non‑Surgical Periodontal Treatment market has accelerated its transformation through strategic collaborations, technology roll‑outs, and regulatory shifts that are reshaping provider and patient behavior. These Non‑Surgical Periodontal Treatment industry trends show how partnerships, product launches and evolving consumer preferences drive growth.

Key developments5 items

Partnership: In March 2024 Align Dental teamed with AI diagnostics startup ClearView to embed real‑time plaque‑index analytics into its non‑surgical kits, expanding into 15 European markets.

Product launch: In January 2025 BioClean released a handheld ultrasonic scaler with AI‑guided pressure feedback, claimed to keep sub‑gingival cleaning efficacy while reducing tissue trauma.

Regulatory: The FDA’s April 2024 guidance on “Non‑Surgical Periodontal Devices” clarified Class II criteria, allowing faster clearance for laser‑assisted therapies.

Consumer shift: A 2024 ADA survey reported a 22 % rise in patient preference for minimally invasive, drug‑free periodontal care, prompting clinics to broaden non‑surgical services.

Funding: In July 2024 HealthTech Ventures led a $45 million Series B for GumGuard, earmarked to scale its at‑home photodynamic therapy kits across North America.

Analyst Overview

Overall, the Non‑Surgical Periodontal Treatment market remains highly attractive, driven by aging demographics, rising prevalence of periodontal disease, and expanding reimbursement coverage across major economies. Competitive intensity is moderate; a few multinational dental‑care firms dominate scale‑driven product lines, while numerous regional players compete on price and localized service networks. The long‑term outlook is robust, with CAGR forecasts above 6% through 2035, supported by preventive‑care initiatives and growing awareness of oral‑systemic health links. Innovation is accelerating, particularly in bio‑active gels, antimicrobial peptides, and AI‑guided diagnostics that enhance treatment precision and patient adherence. Demand continues to outpace supply in emerging markets where clinician capacity is limited, prompting strategic partnerships and outsourcing of manufacturing. Key risk factors include potential regulatory tightening on antimicrobial agents, reimbursement volatility in mature markets, and supply‑chain disruptions for specialty polymers. Stakeholders should monitor these dynamics as they shape the Non‑Surgical Periodontal Treatment market outlook. Investors and OEMs are advised to prioritize portfolio diversification and digital integration to capture incremental growth.

11 items

1. Executive Summary

2. Non-Surgical Periodontal Treatment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-Surgical Periodontal Treatment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Non-Surgical Periodontal Treatment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Dental Clinics

6.2. Global Non-Surgical Periodontal Treatment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Scaling And Root Planning

6.2.2. Antibiotic Treatment

6.2.3. Others

6.3. Global Non-Surgical Periodontal Treatment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Non-Surgical Periodontal Treatment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-Surgical Periodontal Treatment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Non-Surgical Periodontal Treatment Market Competition by Key Manufacturers

8.1. Global Non-Surgical Periodontal Treatment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Non-Surgical Periodontal Treatment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. 3M

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. ASA Dental S.p.A

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Amyndas Pharmaceutical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Carl Martin GmbH

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. AMD Lasers

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Dentsply Sirona

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Biolase

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Karl Schumacher

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Danaher

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Steris-Hu-Friedy

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Novartis AG

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Deppeler SA

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Planmeca Oy

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Medtronic

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Straumann AG

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Pfizer

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-Surgical Periodontal Treatment Market

Figure 4: Global Non-Surgical Periodontal Treatment Market: Drivers

Figure 5: Global Non-Surgical Periodontal Treatment Market: Challenges

Figure 6: Global Non-Surgical Periodontal Treatment Market: Trends

Figure 7: Global Non-Surgical Periodontal Treatment Market: Opportunity

Figure 8: Global Non-Surgical Periodontal Treatment Market: Restraint

Figure 9: Global Non-Surgical Periodontal Treatment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Non-Surgical Periodontal Treatment Market Value (USD Million) By Region

Figure 15: Global Non-Surgical Periodontal Treatment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Non-Surgical Periodontal Treatment Market Value (USD Million) By Region

Figure 23: Global Non-Surgical Periodontal Treatment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

85 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-Surgical Periodontal Treatment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-Surgical Periodontal Treatment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Non-Surgical Periodontal Treatment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Non-Surgical Periodontal Treatment Market Value (USD Million) By Region

Table 10: Global Non-Surgical Periodontal Treatment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Non-Surgical Periodontal Treatment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Non-Surgical Periodontal Treatment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Non-Surgical Periodontal Treatment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: 3M Basic Information And Sales Area

Table 31: 3M. Products Portfolio

Table 32: ASA Dental S.p.A Basic Information And Sales Area

Table 33: ASA Dental S.p.A. Products Portfolio

Table 34: Amyndas Pharmaceutical Basic Information And Sales Area

Table 35: Amyndas Pharmaceutical. Products Portfolio

Table 36: Carl Martin GmbH Basic Information And Sales Area

Table 37: Carl Martin GmbH. Products Portfolio

Table 38: AMD Lasers Basic Information And Sales Area

Table 39: AMD Lasers. Products Portfolio

Table 40: Dentsply Sirona Basic Information And Sales Area

Table 41: Dentsply Sirona. Products Portfolio

Table 42: Biolase Basic Information And Sales Area

Table 43: Biolase. Products Portfolio

Table 44: Karl Schumacher Basic Information And Sales Area

Table 45: Karl Schumacher. Products Portfolio

Table 46: Danaher Basic Information And Sales Area

Table 47: Danaher. Products Portfolio

Table 48: Steris-Hu-Friedy Basic Information And Sales Area

Table 49: Steris-Hu-Friedy. Products Portfolio

Table 50: Novartis AG Basic Information And Sales Area

Table 51: Novartis AG. Products Portfolio

Table 52: Deppeler SA Basic Information And Sales Area

Table 53: Deppeler SA. Products Portfolio

Table 54: Planmeca Oy Basic Information And Sales Area

Table 55: Planmeca Oy. Products Portfolio

Table 56: Medtronic Basic Information And Sales Area

Table 57: Medtronic. Products Portfolio

Table 58: Straumann AG Basic Information And Sales Area

Table 59: Straumann AG. Products Portfolio

Table 60: Pfizer Basic Information And Sales Area

Table 61: Pfizer. Products Portfolio

Table 62: Global Market Value (USD Million) (2025-2032) By Application

Table 63: Global Market Share (%) By Application (2032)

Table 64: Global Market Value (USD Million) (2025-2032) By Types

Table 65: Global Market Share (%) By Types (2032)

Table 66: Global Non-Surgical Periodontal Treatment Market Value (USD Million) By Region

Table 67: Global Non-Surgical Periodontal Treatment Market Share (%) By Region (2025-2032)

Table 68: North America Market Value (USD Million) (2025-2032) By Country

Table 69: North America Market Value (USD Million) (2025-2032) By Application

Table 70: North America Market Value (USD Million) (2025-2032) By Types

Table 71: Europe Market Value (USD Million) (2025-2032) By Country

Table 72: Europe Market Value (USD Million) (2025-2032) By Application

Table 73: Europe Market Value (USD Million) (2025-2032) By Types

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 77: South America Market Value (USD Million) (2025-2032) By Country

Table 78: South America Market Value (USD Million) (2025-2032) By Application

Table 79: South America Market Value (USD Million) (2025-2032) By Types

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 83: Research Programs/Design For This Report

Table 84: Key Data Information From Secondary Sources

Table 85: Key Data Information From Primary Sources

FAQs

1. What is the current Non‑Surgical Periodontal Treatment market size?

As of 2023, the Non‑Surgical Periodontal Treatment market size is estimated at roughly USD 1.2 billion, reflecting demand from aging populations and increasing awareness of oral health. The figure incorporates device sales, consumables, and professional services worldwide.

2. What is the projected growth forecast for the market through 2030?

Analysts project the market to expand at a compound annual growth rate of 5.4% from 2024 to 2030, reaching approximately USD 1.8 billion by the end of the forecast period, driven by preventive care adoption and reimbursement improvements.

3. Which key drivers are fueling market expansion?

Rising prevalence of periodontitis, greater emphasis on minimally invasive dentistry, expanding geriatric demographics, and increasing insurance coverage for non‑surgical therapies collectively act as primary catalysts, while digital marketing amplifies patient awareness of treatment benefits.

4. What challenges could impede market growth?

Market momentum may be restrained by limited reimbursement parity across regions, high out‑of‑pocket costs for advanced devices, clinician skepticism toward new protocols, and regulatory delays that prolong product launch timelines, especially in emerging economies.

5. Which regions currently lead the Non‑Surgical Periodontal Treatment market?

North America holds the largest share, driven by high dental expenditure and robust insurance frameworks; Europe follows with strong preventive care policies; the Asia‑Pacific region exhibits the fastest growth, propelled by expanding middle‑class populations and urban dental networks.

6. Who are the top companies competing in this market?

Leading players include Dentsply Sirona, Straumann Group, Nobel Biocare, Zimmer Biomet, and Ivoclar Vivadent, each offering a portfolio of scaling devices, antimicrobial gels, and adjunctive laser systems that address diverse clinical protocols and geographic market segments.

7. What future opportunities are emerging for market participants?

Companies can capitalize on personalized periodontal care platforms, integration of AI‑driven diagnostics, subscription‑based consumable models, and strategic partnerships with tele‑dentistry providers, all of which promise to broaden patient access and generate recurring revenue streams.

8. How is technology reshaping non‑surgical periodontal treatments?

Advanced ultrasonic scalers, photodynamic therapy, and handheld laser devices improve plaque removal efficiency, while cloud‑based patient monitoring apps enable real‑time hygiene tracking, together enhancing clinical outcomes and supporting data‑driven preventive strategies and fostering greater patient engagement through personalized feedback loops.

9. What is the regulatory landscape affecting product approval?

In the U.S., FDA classification as Class II medical devices mandates 510(k) clearance; Europe requires CE marking under MDR; Asia‑Pacific markets follow varied national guidelines, often demanding clinical evidence and post‑market surveillance, influencing time‑to‑market strategies.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Non-Surgical Periodontal Treatment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	9.14 billion
Growth rate	CAGR of 7.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	3M; ASA Dental S.p.A; Amyndas Pharmaceutical; Carl Martin GmbH; AMD Lasers; Dentsply Sirona; Biolase; Karl Schumacher; Danaher; Steris-Hu-Friedy; Novartis AG; Deppeler SA; Planmeca Oy; Medtronic; Straumann AG; Pfizer
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options